Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin

Predicting chemoresponsiveness in epithelial ovarian cancer patients using circulating small extracellular vesicle-derived plasma gelsolin

Abstract Background Resistance to chemotherapy continues to be a challenge when treating epithelial ovarian cancer (EOC), contributing to low patient survival rates. While CA125, the conventional EOC biomarker, has been useful in monitoring patients’ response to therapy, there are no biomarkers used...

Full description

Bibliographic Details
Main Authors: Emma Gerber, Meshach Asare-Werehene, Arkadiy Reunov, Dylan Burger, Tien Le, Euridice Carmona, Anne-Marie Mes-Masson, Benjamin K. Tsang
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Journal of Ovarian Research
Subjects:
Epithelial ovarian cancer
Chemoresistance
Biomarkers
Plasma gelsolin
Small extracellular vesicles
CA125
Online Access:https://doi.org/10.1186/s13048-022-01086-x

Internet

https://doi.org/10.1186/s13048-022-01086-x

Similar Items